标题
Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2015, Issue -, Pages 1-6
出版商
Hindawi Limited
发表日期
2015-10-13
DOI
10.1155/2015/606819
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells
- (2015) M. Lu et al. BLOOD
- JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib
- (2015) L. Pieri et al. BLOOD
- MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling
- (2015) K. Rozenova et al. BLOOD
- IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
- (2015) Lukas F. Mager et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosis
- (2015) John Mascarenhas LEUKEMIA & LYMPHOMA
- Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells
- (2015) Dagmar Walter et al. NATURE
- JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
- (2015) M. Kleppe et al. Cancer Discovery
- The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm
- (2014) V. Sangkhae et al. BLOOD
- JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2
- (2014) Y. Kagoya et al. BLOOD
- Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
- (2014) James D. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value
- (2014) A M Vannucchi et al. LEUKEMIA
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Immune Dysregulation in MPN
- (2014) Giovanni Barosi Current Hematologic Malignancy Reports
- Emerging role of interleukin-33 in autoimmune diseases
- (2013) Cheng Pei et al. IMMUNOLOGY
- A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression
- (2013) C Marty et al. LEUKEMIA
- Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia
- (2013) Pedro Ramos et al. NATURE MEDICINE
- CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress
- (2013) Andrew Chow et al. NATURE MEDICINE
- Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
- (2012) H. C. Hasselbalch BLOOD
- Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes
- (2012) C. Pecquet et al. BLOOD
- Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
- (2012) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- TNF facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
- (2011) A. G. Fleischman et al. BLOOD
- FLT3-Mediated p38-MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis
- (2011) C. Desterke et al. CANCER RESEARCH
- The Thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis
- (2011) Fu-Sheng Chou et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Chronic Exposure to a TLR Ligand Injures Hematopoietic Stem Cells
- (2011) B. L. Esplin et al. JOURNAL OF IMMUNOLOGY
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- Abnormal immunity and stem/progenitor cells in acquired aplastic anemia
- (2010) Jian Ping Li et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Autoimmunity and the risk of myeloproliferative neoplasms
- (2010) S. Y. Kristinsson et al. HAEMATOLOGICA
- Thrombopoietin Receptor Activation, Thrombopoietin Mimetic Drugs, and Hereditary Thrombocytosis: Remarks on Bone Marrow Fibrosis
- (2010) Luciana Teofili et al. JOURNAL OF CLINICAL ONCOLOGY
- Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis?
- (2010) Giovanni Barosi et al. LEUKEMIA RESEARCH
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F
- (2010) M Boissinot et al. ONCOGENE
- Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2
- (2008) Alexey Bersenev et al. JOURNAL OF CLINICAL INVESTIGATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started